Ascendis Pharma A/S vs Invesco Galaxy Bitcoin ETF — how do they compare? Ascendis Pharma A/S trades at $254.5 (market cap $16.67B), while Invesco Galaxy Bitcoin ETF trades at $63.04. The key difference: Ascendis Pharma A/S is trading nearer its 52-week high, Invesco Galaxy Bitcoin ETF nearer its low. Which is the better fit depends on your goals.
| ASND | BTCO | |
|---|---|---|
Market Cap | $16.67B | — |
Sector | Health | Crypto-linked |
52-Week High | $277.18 | $125.14 |
52-Week Low | $189.74 | $58.40 |
Enterprise Value | $17.04B | — |
Trailing returns across standard periods
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →BTCO is a spot Bitcoin ETF that tracks the price of Bitcoin directly. It offers investors a regulated and convenient way to gain exposure to the digital currency through a traditional brokerage account without holding the asset.
Read more on BTCO →